Prempro
Product Images NDC 69189-1107

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Prempro (NDC 69189-1107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avera Mckennan Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Estrogens Conjugated/medroxyprogesterone 0.625/2.5mg Tablet (6918911071)

Prempro 0.625/2.5 mg tablet label showing the proprietary name, partial active ingredients (estrog conj/medrox), product code 6918911071, manufacturer Wyeth, and expiration date 01/27/2017. The label is small, white, and affixed to a blister pack with a blue corner visible.*

FDA Label Image

Chemical Structure (Prempro 01)

Chemical structure of the active ingredient for Prempro labeled by Avera McKennan Hospital. The structure depicts a steroid framework with multiple rings, methyl groups, and ester functional groups consistent with hormonal components.*

FDA Label Image

Figure 1 (Prempro 02)

A line graph showing the percentage of patients over treatment cycles. Two data series are plotted, each represented by different symbols, depicting patient percentages across 13 cycles. The x-axis is labeled 'Cycle' and the y-axis '% of Patients'. A legend identifies the two series by dosing regimens.*

FDA Label Image

Figure 2 (Prempro 03)

A line graph showing the percentage of patients over 13 cycles for three different CE/MPA dosage groups: 0.625/2.5, 0.45/1.5, and 0.3/1.5. The y-axis represents the percentage of patients from 0 to 100, and the x-axis represents the cycle number from 1 to 13. Each dosage group is represented by a distinct line pattern and shape indicating patient progression through cycles.*

FDA Label Image

Figure 3 (Prempro 04)

A cumulative percent of subjects graph showing percent change from baseline in spine bone mineral density (BMD). The plot includes four curves labeled as 0.625/2.5, 0.45/1.5, 0.3/1.5, and placebo, representing different treatment groups or dosages, with the x-axis displaying percent change and the y-axis showing cumulative percent of subjects.*

FDA Label Image

Figure 4 (Prempro 05)

A line graph showing adjusted percent change from baseline over multiple cycles for four groups: 0.625/2.5, 0.45/1.5, 0.3/1.5, and placebo. The x-axis represents the cycle number (0, 6, 13, 19, 26), and the y-axis represents adjusted percent change, with values ranging from -4 to 5. Data points include error bars and show trends for each group across cycles.*

FDA Label Image

Logo (Prempro 06)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.